Rethinking arterial lines

The EVERDAC trial challenges the clinical dogma of routine arterial catheterization in patients with shock, demonstrating that a non-invasive monitoring strategy is non-inferior to early invasive catheterization regarding 28-day all-cause mortality. Dr. Gregoire Muller, lead author of the study, explains that while arterial lines are useful for specific hemodynamic assessments like pulse pressure or cardiac output, they are not mandatory for initial resuscitation. The trial reveals that non-invasive monitoring provides sufficient accuracy for mean arterial pressure in the vast majority of cases, while avoiding complications such as hematomas, infections, and anemia from excessive blood sampling. These findings suggest that clinicians should prioritize patient-centered, less invasive approaches, reserving arterial lines for patients who specifically require advanced hemodynamic data or have failed non-invasive monitoring, rather than treating them as a standard procedure upon ICU admission.